Rachel R. Luba

This study tests whether a long-acting injectable form of buprenorphine works better than the standard sublingual (under-the-tongue) version for treating opioid use disorder in people who use fentanyl or other strong synthetic opioids. About 60 adults aged 18–65 will be enrolled …